Yvonne de Knegt

Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients

Annemiek Broyl, Dirk Hose, Henk M. Lokhorst et al. · Blood · 2010 · 336 citations · Full text

A gene expression signature for high-risk multiple myeloma

Rowan Kuiper, Annemiek Broyl, Yvonne de Knegt et al. · Leukemia · 2012 · 297 citations

Hematological Malignancy, Tumor Biology, Gene Expression Signature +7

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial

Annemiek Broyl, Sophie L. Corthals, Joost L.M. Jongen et al. · The Lancet Oncology · 2010 · 220 citations

Hematological Malignancy, Neuro-oncology, Peripheral Neuropathy +8

Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Dominik Spensberger, Yvonne de Knegt et al. · Oncogene · 2005 · 73 citations

Hematological Malignancy, Medicine, Genetics +9

Cancer testis antigens in newly diagnosed and relapse multiple myeloma: prognostic markers and potential targets for immunotherapy

Mark van Duin, Annemiek Broyl, Yvonne de Knegt et al. · Haematologica · 2011 · 69 citations · Full text